Status:
UNKNOWN
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer
Lead Sponsor:
Odense University Hospital
Collaborating Sponsors:
Zealand University Hospital
Conditions:
Prostate Cancer
Androgen Deprivation Therapy
Eligibility:
MALE
Phase:
PHASE3
Brief Summary
The purpose of this study is * to determine the rate of osteoporosis among patients with advanced prostate cancer. * to propose an algorithm for early detection of patients with advanced prostate can...
Detailed Description
Patients with advanced prostate cancer are included at the initiating of androgen deprivation therapy. The patients are followed for 2 years after inclusion with blood sampling, DXA-scan, questionnai...
Eligibility Criteria
Inclusion
- Prostate cancer
- Initiation of androgen deprivation therapy
- Oral and written informed consent
Exclusion
- They withdraw their consent
- Treatment for osteoporosis within the last year
- Other malignancy
- Other bone disease, bedbound, use of steroid
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00957606
Start Date
August 1 2009
End Date
September 1 2013
Last Update
April 13 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, Odense University Hospital
Odense, Denmark, 5000
2
Department of Urology, Roskilde Hospital
Roskilde, Denmark, 4000